Online inquiry

IVTScrip™ mRNA-Human AGBL4-IT1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9593MR)

This product GTTS-WK9593MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AGBL4-IT1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 100874313
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGBL4-IT1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK9593MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11530MR IVTScrip™ mRNA-Human ACN9, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACN9
GTTS-WK5187MR IVTScrip™ mRNA-Human SBSN, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA SBSN
GTTS-WK3987MR IVTScrip™ mRNA-Human SBSN, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA SBSN
GTTS-WK12625MR IVTScrip™ mRNA-Human ABALON, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ABALON
GTTS-WK5630MR IVTScrip™ mRNA-Human human myeloid inhibitory C-lectin, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA hMICL
GTTS-WK3230MR IVTScrip™ mRNA-Human human myeloid inhibitory C-lectin, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA hMICL
GTTS-WK7885MR IVTScrip™ mRNA-Human AC002467.7, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AC002467.7
GTTS-WK8495MR IVTScrip™ mRNA-Human AC092580.4, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AC092580.4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →